2019, Número 2
<< Anterior Siguiente >>
Cardiovasc Metab Sci 2019; 30 (2)
Infarto sincrónico cardio-cerebral no hiperagudo tratado con doble terapia intervencionista
Plata-Corona JC, Cerón-Morales JA, Lara-Solís B
Idioma: Inglés [English version]
Referencias bibliográficas: 40
Paginas: 66-75
Archivo PDF: 363.29 Kb.
RESUMEN
Introducción: La aparición simultánea de infarto agudo de miocardio y evento vascular cerebral isquémico es conocida como infarto cardiocerebral (ICC), esta asociación es extremadamente infrecuente y representa un escenario complejo de cara al tratamiento. En estos casos generalmente hay una causa subyacente que vincula ambos eventos trombóticos. El reconocimiento simultáneo de estas dos condiciones es difícil en términos clínicos, y en muchos de los casos se llega a demostrar únicamente mediante autopsia.
Objetivos: En la presente revisión se aborda la epidemiología, fisiopatología y el tratamiento del ICC dentro de la literatura actual.
Caso clínico: Masculino de 46 años, diagnosticado de ICC después de cinco horas de iniciado su cuadro clínico, decidimos realizar un doble abordaje percutáneo con trombólisis intraarterial más trombectomía mecánica de la arteria cerebral media derecha asociada a coronariografía con angioplastia y colocación de stent en el segmento proximal de la arteria descendente anterior.
Resultados: La recuperación del paciente fue favorable, egresándose al tercer día sin datos de falla cardiaca y con Rankin score modificado de 2, y de 0 al mes.
Conclusión: El ICC es poco común y con frecuencia devastador. Se necesitan más estudios para establecer estrategias adecuadas de tratamiento, sin embargo, la rareza de esta condición hace difícil establecer ensayos clínicos para su estudio. Basados en los resultados obtenidos en este caso en particular, sugerimos un abordaje endovascular combinado en pacientes con ICC sincrónico no hiperagudo.
REFERENCIAS (EN ESTE ARTÍCULO)
Jong Kyu P, Sang-Hak L, Seonghoon C, Jae-Hun J, Namho L. Two patients with acute myocardial infarction presenting with simultaneous acute ischemic stroke. Korean J Med. 2008; 74 (6): 672-625.
Akinseye OA, Shahreyar M, Heckle MR, Khouzam RN. Simultaneous acute cardio-cerebral infarction: is there a consensus for management? Ann Transl Med. 2018; 6 (1): 7.
Omar HR, Fathy A, Rashad R, Helal E. Concomitant acute right ventricular infarction and ischemic cerebrovascular stroke; possible explanations. Int Arch Med. 2010; 3: 25.
Yeo LLL, Andersson T, Yee KW, Tan BYQ, Paliwal P, Gopinathan A et al. Synchronous cardiocerebral infarction in the era of endovascular therapy: which to treat first? J Thromb Thrombolysis. 2017; 44 (1): 104-111.
Kijpaisalratana N, Chutinet A, Suwanwela NC. Hyperacute simultaneous cardiocerebral infarction: rescuing the brain or the heart first? Front Neurol. 2017; 8: 664.
Budaj A, Flasinska K, Gore JM, Anderson FA, Dabbous OH, Spencer FA et al. Magnitude of and risk factors for in-hospital and postdischarge stroke in patients with acute coronary syndromes. Circulation. 2005; 111 (24): 3242-3247.
Gattringer T, Niederkorn K, Seyfang L, Seifert-Held T, Simmet N, Ferrari J et al. Myocardial infarction as a complication in acute stroke: results from the austrian stroke unit registry. Cerebrovasc Dis. 2014; 37 (2): 147-152.
Mochmann H-C, Scheitz JF, Petzold GC, Haeusler KG, Audebert HJ, Laufs U et al. Coronary angiographic findings in acute ischemic stroke patients with elevated cardiac troponin. Circulation. 2016; 133 (13): 1264- 1271.
Gianstefani S, Douiri A, Delithanasis I, Rogers T, Sen A, Kalra S et al. Incidence and predictors of early left ventricular thrombus after ST-elevation myocardial infarction in the contemporary era of primary percutaneous coronary intervention. Am J Cardiol. 2014; 113 (7): 1111-1116.
Delewi R, Zijlstra F, Piek JJ. Left ventricular thrombus formation after acute myocardial infarction. Heart. 2012; 98 (23): 1743-1749.
Vaitkus PT, Barnathan E. Embolic potential, prevention and management of mural thrombus complicating anterior myocardial infarction: a meta-analysis. 1993; 1004-1009.
Tokuda K, Shindo S, Yamada K, Shirakawa M, Uchida K, Horimatsu T et al. Acute embolic cerebral infarction and coronary artery embolism in a patient with atrial fibrillation caused by similar thrombi. J Stroke Cerebrovasc Dis. 2016; 25 (7): 1797-1799.
Grogono J, Fitzsimmons S, Shah B, Rakhit D, Gray H. Simultaneous myocardial infarction and ischaemic stroke secondary to paradoxical emboli through a patent foramen ovale. 2012; 391-392.
Bladin CF, Chambers BR. Frequency and pathogenesis of hemodynamic stroke. 1994. pp. 2179-2182.
Dobkin B. Orthostatic hypotension as a risk factor for symptomatic occlusive cerebrovascular disease. 1989. pp. 30-34.
Ryan D, Kenny R, Christensen S, Meaney J, Fagan A, Harbison J. Ischaemic stroke or TIA in older subjects associated with impaired dynamic blood pressure control in the absence of severe large artery stenosis. 2015.
Nguyen TL, Rajaratnam R. Dissecting out the cause: a case of concurrent acute myocardial infarction and stroke. 2011;
Laowattana S, Zeger SL, Lima JAC, Goodman SN, Wittstein IS, Oppenheimer SM. Left insular stroke is associated with adverse cardiac outcome. Neurology. 2006; 66 (4): 477-4783.
Nagai M, Hoshide S, Kario K. The insular cortex and cardiovascular system: a new insight into the brainheart axis. J Am Soc Hypertens. 2010; 4 (4): 174-182.
Christensen H, Boysen G, Christensen AF, Johannesen HH. Insular lesions, ECG abnormalities, and outcome in acute stroke. J Neurol Neurosurg Psychiatry. 2005; 76 (2): 269-271.
Ay H, Koroshetz WJ, Benner T, Vangel MG, Melinosky C, Arsava EM et al. Neuroanatomic correlates of strokerelated myocardial injury. Neurology. 2006; 66 (9): 1325-1329.
Cheshire WP, Saper CB. The insular cortex and cardiac response to stroke. Neurology. 2006; 66 (9): 1296- 1297.
Hosoya H, Levine JJ, Henry DH, Goldberg S. Double the trouble: acute coronary syndrome and ischemic stroke in polycythemia vera. The Am J Med. 2017; 130 (6): e237-e240.
Jauch EC, Saver JL, Adams HP, Bruno A, Connors JJ, Demaerschalk BM et al. Guidelines for the early management of patients with acute ischemic stroke. Stroke. 2013; 44 (3): 870-947.
De Silva DA, Manzano JJF, Chang HM, Wong MC. Reconsidering recent myocardial infarction as a contraindication for IV stroke thrombolysis. Neurology. 2011; 76 (21): 1838-1840.
Bueno H, Martínez-Sellés M, Pérez-David E, López- Palop R. Effect of thrombolytic therapy on the risk of cardiac rupture and mortality in older patients with first acute myocardial infarction. 2005; 1705-1711.
Chang RY, Tsai HL, Hsiao PG, Tan CW, Lee CP, Chu IT et al. Comparison of the risk of left ventricular free wall rupture in Taiwanese patients with ST-elevation acute myocardial infarction undergoing different reperfusion strategies: a medical record review study. 2016; e5308.
Patel M, J Meine T, Lindblad L, Griffin J, Granger C, Becker RC et al. Cardiac tamponade in the fibrinolytic era: analysis of > 100,000 patients with ST-segment elevation myocardial infarction. 2006; 316-322.
Omar H, Mangar D, Camporesi E. Simultaneous thrombosis of 2 vascular territories: is thrombolytic therapy a better option? 2013.
Álvarez-Sabín J, Maisterra O, Santamarina E, Kase CS. Factors influencing haemorrhagic transformation in ischaemic stroke. Lancet Neurol. 2013; 12 (7): 689-705.
Brott TG, Haley EC, Levy D, Barsan W, Broderick J, Sheppard GL et al. Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes. 1992; 632-640.
Messé SR, Tanne D, Demchuk A, Cucchiara B, Levine SR, Kasner S. Dosing errors may impact the risk of rt-PA for stroke: the multicenter rt-PA acute stroke survey. 2004; 35-40.
Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K et al. 2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2018; 49 (3): e46-e99.
Demaerschalk BM, Kleindorfer DO, Adeoye OM, Demchuk AM, Fugate JE, Grotta JC et al. Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke. Stroke. 2016; 47 (2): 581-641.
Maciel R, Palma R, Sousa P, Ferreira F, Nzwalo H. Acute stroke with concomitant acute myocardial infarction: will you thrombolyse? 2015.
Goyal M, Demchuk A, Menon B, Eesa M, Rempel J, Thornton J et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. 2015.
Campbell B, Mitchell P, Kleinig T, Dewey HM, Churilov L, Yassi N et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. 2015.
Noser EA, Shaltoni HM, Hall CE, Alexandrov AV, Garami Z, Cacayorin ED et al. Aggressive mechanical clot disruption: a safe adjunct to thrombolytic therapy in acute stroke? Stroke. 2005; 36 (2): 292-296.
Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015; 372 (1): 11-20.
Heiferman DM, Li DD, Pecoraro NC, Smolenski AM, Tsimpas A, Ashley WW, Jr. Intra-arterial alteplase thrombolysis during mechanical thrombectomy for acute ischemic stroke. J Stroke Cerebrovasc Dis. 2017; 26 (12): 3004-3008.